Search research articles
Contact Us
Filters
Showing results (1-10 of 94) with videos related to
Page
of 10
Sort By:
Annual Review of Medicine
|
January 16, 2016
B-Raf Inhibition in the Clinic: Present and Future
Warren Fiskus, Nicholas Mitsiades
Blood
|
May 7, 2016
NEDD8 and HDACs: promising cotargets in AML
Kapil N Bhalla, Warren Fiskus
Cancer Biology & Therapy
|
April 14, 2009
Activation of mTOR: A new mechanism "PIMed"
Kathleen Buckley, Warren Fiskus, Kapil Bhalla
Cancer Journal (Sudbury, Mass.)
|
September 20, 2017
Targeting Histone Acetylation: Readers and Writers in Leukemia and Cancer
Christopher B Benton, Warren Fiskus, Kapil N Bhalla
Hematology/Oncology Clinics of North America
|
September 27, 2012
Role of additional novel therapies in myeloproliferative neoplasms
Warren Fiskus, Siddhartha Ganguly, Suman Kambhampati, et al.
Oncotarget
|
December 8, 2017
Targeting cistrome and dysregulated transcriptome of post-MPN sAML
Srdan Verstovsek, Warren Fiskus, Taghi Manshouri, et al.
DNA and Cell Biology
|
August 28, 2003
Molecular cloning and analysis of a region of the Bartonella bacilliformis genome encoding NlpD, L-isoaspartyl methyltransferase and YajC homologs
Indira Padmalayam, Warren Fiskus, Robert F Massung, et al.
Advances in Cancer Research
|
October 24, 2012
HDAC inhibitors and chaperone function
Rekha Rao, Warren Fiskus, Siddhartha Ganguly, et al.
DNA and Cell Biology
|
December 9, 2003
Identification and characterization of the DdlB, FtsQ and FtsA genes upstream of FtsZ in Bartonella bacilliformis and Bartonella henselae
Warren Fiskus, Indira Padmalayam, Tim Kelly, et al.
Oncotarget
|
December 13, 2012
Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer
Sreedhar Venkannagari, Warren Fiskus, Karissa Peth, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 94) with videos related to
Sort By:
Page
of 10
Annual Review of Medicine
|
January 16, 2016
B-Raf Inhibition in the Clinic: Present and Future
Warren Fiskus, Nicholas Mitsiades
Blood
|
May 7, 2016
NEDD8 and HDACs: promising cotargets in AML
Kapil N Bhalla, Warren Fiskus
Cancer Biology & Therapy
|
April 14, 2009
Activation of mTOR: A new mechanism "PIMed"
Kathleen Buckley, Warren Fiskus, Kapil Bhalla
Cancer Journal (Sudbury, Mass.)
|
September 20, 2017
Targeting Histone Acetylation: Readers and Writers in Leukemia and Cancer
Christopher B Benton, Warren Fiskus, Kapil N Bhalla
Hematology/Oncology Clinics of North America
|
September 27, 2012
Role of additional novel therapies in myeloproliferative neoplasms
Warren Fiskus, Siddhartha Ganguly, Suman Kambhampati, et al.
Oncotarget
|
December 8, 2017
Targeting cistrome and dysregulated transcriptome of post-MPN sAML
Srdan Verstovsek, Warren Fiskus, Taghi Manshouri, et al.
DNA and Cell Biology
|
August 28, 2003
Molecular cloning and analysis of a region of the Bartonella bacilliformis genome encoding NlpD, L-isoaspartyl methyltransferase and YajC homologs
Indira Padmalayam, Warren Fiskus, Robert F Massung, et al.
Advances in Cancer Research
|
October 24, 2012
HDAC inhibitors and chaperone function
Rekha Rao, Warren Fiskus, Siddhartha Ganguly, et al.
DNA and Cell Biology
|
December 9, 2003
Identification and characterization of the DdlB, FtsQ and FtsA genes upstream of FtsZ in Bartonella bacilliformis and Bartonella henselae
Warren Fiskus, Indira Padmalayam, Tim Kelly, et al.
Oncotarget
|
December 13, 2012
Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer
Sreedhar Venkannagari, Warren Fiskus, Karissa Peth, et al.
Page
of 10